Table 2: Comparison of clinical characteristics of patients with mild and moderate-severe community-acquired pneumonia (CAP)

 

Characteristic                                                                      

All patients With

CAP  (n = 209)

Patients with mild

 CAP (n = 53)

Patients with moderate-severe CAP (n = 156)

p-value

 

Age (years)                                                     

 

71.36 ± 12.93

 

62.08 ± 14.81

 

74.36 ± 10.78

 

< 0.0001

Gender                                             

 

 

 

0.34

         Male

107 (51.20%)

24 (45.28%)

83 (53.21%)

 

         Female

102 (78.80%)

29 (54.72%)

73 (46.79%)

 

Co-morbid Conditions

 

 

 

 

Chronic heart disease                                    

164 (78.47%)

32 (60.38%)

132 (84.62%)

< 0.0001

Chronic lung disease                                       

80 (38.28%)

18 (33.95%)

62 (39.74%)

0.52

Cancer                                                            

47 (22.49%)

5 (9.43%)

42 (26.92%)

0.01

Neurologic disease                                          

50 (23.92%)

4 (7.55%)

46 (29.49%)

0.001

Chronic renal disease    

48 (22.97%)

4 (7.55%)

44 (28.21%)

0.001

Patients from LTCF

33 (15.79%)

2 (3.77%)

31 (19.87%)

0.004

Systemic steroids use                                

57 (27.27%)

16 (30.19%)

41 (26.28%)

0.60

Duration of symptoms before presentation (days)

4.94 ± 5.26

5.10 ± 5.04

4.95 ± 5.44

0.86

Hospitalization in last 90 days                     

39 (18.75%)

4 (7.55%)

35 (22.58%)

0.02

Weekend admission

67 (32.06%)

18 (33.96%)

49 (31.41%)

0.74

Time to first appropriate antibiotic since time of triage (hours)

6.16 ± 7.94

4.60 ± 3.43

6.62 ± 9.01

0.02

First appropriate antibiotic  >4hours since time of triage

96 (45.93%)

23 (43.04%)

73 (46.79%)

0.75

Time to first appropriate antibiotic since time of physician assessment (hours)

4.50 ± 4.73

3.21 ± 3.13

4.80 ± 5.08

0.02

Time seen by physician since time of triage (hours)

1.0 ± 1.20

1.19 ± 1.24

0.95 ± 1.20

0.25

Duration of antibiotics(days)                                 

10.79 ± 4.20

9.91 ± 2.63

11.05 ± 4.61

0.03

Length of hospital stay (days)

9.47 ± 9.70

6.42 ± 5.79

10.48 ± 10.53

0.001

Patients on macrolide

115 (55.02%)

35 (66.04%)

80 (51.28%)

0.08

Patients on fluoroquinlones

56 (26.79%)

13 (24.53%)

43 (27.56%)

0.72

 Positive culture (respiratory or blood)

22 (10.53%)

9 (16.98%)

13 (8.33%)

0.13

Complications

91 (43.54%)

10 (18.87%)

81 (51.92%)

< 0.0001

Complications within 24 hours of admission

60 (28.71%)

6 (11.32%)

54 (34.62%)

0.001

Complications after 24 hours of admission

65 (31.10%)

6 (11.32%)

59 (37.82%)

0.0002

Cardiac complications

17 (8.13%)

4 (7.55%)

13 (8.33%)

1.00

Respiratory failure

41 (19.61%)

1 (1.89%)

40 (25.64%)

< 0.0001

Septic Shock

4 (1.91%)

0

4 (2.56%)

0.57

Empyema

1 (0.48%)

0

1 (0.46%)

1.000

Cardiac ischemia

7 (3.35%)

1 (1.89%)

6 (3.85%)

0.68

Arrhythmias

12 (5.74%)

3 (5.66%)

9 (5.77%)

1.000

Intensive care admission

25 (11.96%)

0

25 (16.03%)

0.001

Others complications

28 (13.40%)

4 (14.29%)

24 (15.48%)

0.17

Death

32 (15.31%)

1 (1.89%)

31 (19.87%)

0.001

 

LTCF: long term care facility

 

Data expressed as mean ± SD or frequency and percentage as indicated.